Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Overall

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Analytical Biochemistry|August 15, 1987
A microtechnique for dialysis of small volume solutions with quantitative recoveriesC M Overall
Journal of Cellular Physiology|July 1, 1995
Repression of tissue inhibitor of matrix metalloproteinase expression by all-trans-retinoic acid in rat bone cell populations: comparison with transforming growth factor-beta 1C M Overall
Matrix (Stuttgart, Germany). Supplement|January 1, 1992
Matrix metalloproteinases in periodontal tissue remodellingJ Sodek, C M Overall
British Journal of Cancer|March 16, 2006
Towards third generation matrix metalloproteinase inhibitors for cancer therapyC M Overall, O Kleifeld
The Biochemical Journal|December 15, 1988
Identification and characterization of enamel proteinases isolated from developing enamel. Amelogeninolytic serine proteinases are associated with enamel maturation in pigC M Overall, H Limeback
Journal of Dental Research|July 1, 1987
Initial characterization of a neutral metalloproteinase, active on native 3/4-collagen fragments, synthesized by ROS 17/2.8 osteoblastic cells, periodontal fibroblasts, and identified in gingival crevicular fluidC M Overall, J Sodek
The Journal of Biological Chemistry|December 5, 1990
Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinasesC M Overall, J Sodek
The Journal of Biological Chemistry|March 14, 1997
The hemopexin-like domain (C domain) of human gelatinase A (matrix metalloproteinase-2) requires Ca2+ for fibronectin and heparin binding. Binding properties of recombinant gelatinase A C domain to extracellular matrix and basement membrane componentsU M Wallon, C M Overall
Current Pharmaceutical Design|February 23, 2007
Proteomic validation of protease drug targets: pharmacoproteomics of matrix metalloproteinase inhibitor drugs using isotope-coded affinity tag labelling and tandem mass spectrometryG S Butler, C M Overall
Journal (Canadian Dental Association)|May 1, 1995
Papillon-Lefèvre syndrome associated early onset periodontitis: a review and case studyD French, H Scott, C M Overall
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Analytical Biochemistry|August 15, 1987
A microtechnique for dialysis of small volume solutions with quantitative recoveriesC M Overall
Journal of Cellular Physiology|July 1, 1995
Repression of tissue inhibitor of matrix metalloproteinase expression by all-trans-retinoic acid in rat bone cell populations: comparison with transforming growth factor-beta 1C M Overall
Matrix (Stuttgart, Germany). Supplement|January 1, 1992
Matrix metalloproteinases in periodontal tissue remodellingJ Sodek, C M Overall
British Journal of Cancer|March 16, 2006
Towards third generation matrix metalloproteinase inhibitors for cancer therapyC M Overall, O Kleifeld
The Biochemical Journal|December 15, 1988
Identification and characterization of enamel proteinases isolated from developing enamel. Amelogeninolytic serine proteinases are associated with enamel maturation in pigC M Overall, H Limeback
Journal of Dental Research|July 1, 1987
Initial characterization of a neutral metalloproteinase, active on native 3/4-collagen fragments, synthesized by ROS 17/2.8 osteoblastic cells, periodontal fibroblasts, and identified in gingival crevicular fluidC M Overall, J Sodek
The Journal of Biological Chemistry|December 5, 1990
Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinasesC M Overall, J Sodek
The Journal of Biological Chemistry|March 14, 1997
The hemopexin-like domain (C domain) of human gelatinase A (matrix metalloproteinase-2) requires Ca2+ for fibronectin and heparin binding. Binding properties of recombinant gelatinase A C domain to extracellular matrix and basement membrane componentsU M Wallon, C M Overall
Current Pharmaceutical Design|February 23, 2007
Proteomic validation of protease drug targets: pharmacoproteomics of matrix metalloproteinase inhibitor drugs using isotope-coded affinity tag labelling and tandem mass spectrometryG S Butler, C M Overall
Journal (Canadian Dental Association)|May 1, 1995
Papillon-Lefèvre syndrome associated early onset periodontitis: a review and case studyD French, H Scott, C M Overall
Pageof 6